deltatrials
Unknown PHASE2 INTERVENTIONAL 1-arm NCT02215447

A Feasibility Study Of NAB-Paclitaxel In Combination With Carboplatin As First Line Treatment Of Gastrointestinal Neuroendocrine Carcinomas (NABNEC)

Sponsor: Australasian Gastro-Intestinal Trials Group

Conditions Gastrointestinal Neuroendocrine Carcinomas
Interventions Carboplatin NAB paclitaxel
Updated 8 times since 2017 Last updated: Nov 20, 2017 Started: May 31, 2015 Primary completion: Nov 30, 2018 Completion: Oct 31, 2020
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Gastrointestinal Neuroendocrine Carcinomas, this trial is ongoing. The trial is conducted by Australasian Gastro-Intestinal Trials Group and has accumulated 8 data snapshots since 2015. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

~Jan 2017 – ~Aug 2017 · 7 months · monthly snapshotRecruiting~Aug 2017 – ~Dec 2017 · 4 months · monthly snapshotActive Not Recruiting~Dec 2017 – ~Jun 2018 · 6 months · monthly snapshotActive Not Recruiting~Jun 2018 – ~Nov 2020 · 29 months · monthly snapshotActive Not Recruiting~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshotUnknown Status~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotUnknown Status~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotUnknown~Sep 2024 – present · 22 months · monthly snapshotUnknown

Change History

8 versions recorded

  1. Sep 2024 — Present [monthly]

    Unknown PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Unknown PHASE2

    Status: Unknown Status → Unknown

  3. Jan 2021 — Jul 2024 [monthly]

    Unknown Status PHASE2

  4. Nov 2020 — Jan 2021 [monthly]

    Unknown Status PHASE2

    Status: Active Not Recruiting → Unknown Status

  5. Jun 2018 — Nov 2020 [monthly]

    Active Not Recruiting PHASE2

▶ Show 3 earlier versions

  1. Dec 2017 — Jun 2018 [monthly]

    Active Not Recruiting PHASE2

  2. Aug 2017 — Dec 2017 [monthly]

    Active Not Recruiting PHASE2

    Status: Recruiting → Active Not Recruiting

  3. Jan 2017 — Aug 2017 [monthly]

    Recruiting PHASE2

    First recorded

May 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Australasian Gastro-Intestinal Trials Group
  • Barwon Health
  • Deakin University
  • Specialised Therapeutics Australia
Data source: Barwon Health

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations